Day One Biopharmaceuticals, Inc. - Rasio nilai perusahaan marang dodolan DAWN

Simbol resmi perusahaan dayonebio.com (DAWN)

Developing pediatric oncology drugs within a narrow segment entails significant trial difficulties. The EV/Sales ratio reflects the business valuation trend, with the metric currently standing at 11293.27. Day One (DAWN) is protected from industry behemoths by its monopoly position in the glioma niche thanks to Ojemda. A strong scientific team, retained through a stock option system, ensures stability.

Day One Biopharmaceuticals Inc (DAWN): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 09.05.2026

Day One Bio - rincian analitis lan metrik utama (DAWN)

- rega lan prakiraan konsensus rega:
Pambiji fundamental perusahaan:DAWN, dayonebio.com
Produk sing diprodhuksi Day One Biopharmaceuticals, Inc.

Professional selection of blue-chip assets requires a rigorous analysis of business value relative to its operating income. This indicator compares the total enterprise value of a company, including debt, against annual revenue to determine the market premium. For Day One (DAWN), this calculation is critical, as massive R&D expenditures and patent protection create a high barrier to entry. The valuation dynamics of Day One (DAWN) based on the EV/Sales multiple reflect market expectations regarding FDA approvals.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan MNPR|Multiplikator nilai perusahaan marang pendapatan Inhibrx Biosciences INBX|Nilai perusahaan marang pendapatan IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Nilai bisnis marang pendapatan|Heron Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CRBP (Corbus Pharma)|CRDF: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan beyondspringpharma.com (BYSI)|Rasio nilai perusahaan marang pendapatan bioatla.com|LIXT: Nilai bisnis marang pendapatan|Multiplikator EV/Sales CTXR|Multiplikator EV/Sales Cellectar Corp (CLRB)|Rasio nilai perusahaan marang pendapatan BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Nilai perusahaan marang volume dodolan|APRE: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales